The relevance of AREG inhibition is further highlighted by the observed changes in the expression of the ErbB receptor family (ErbB1-ErbB4), which comprises a network of receptor tyrosine kinases fundamental to epithelial carcinoma biology. This evidence concerns the gene NTRK1 and carcinoma.